Published in AIDS on March 12, 2007
Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system. J Clin Endocrinol Metab (2008) 3.64
Microbial translocation across the GI tract. Annu Rev Immunol (2012) 2.30
Bone disease in HIV infection: a practical review and recommendations for HIV care providers. Clin Infect Dis (2010) 2.20
Increased risk of fragility fractures among HIV infected compared to uninfected male veterans. PLoS One (2011) 2.11
Continuous antiretroviral therapy decreases bone mineral density. AIDS (2009) 1.96
HIV infection in the elderly. Clin Interv Aging (2008) 1.59
Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults. AIDS (2009) 1.46
Association of age and comorbidity with physical function in HIV-infected and uninfected patients: results from the Veterans Aging Cohort Study. AIDS Patient Care STDS (2011) 1.37
HIV infection and older Americans: the public health perspective. Am J Public Health (2012) 1.31
Incident fractures in HIV-infected individuals: a systematic review and meta-analysis. AIDS (2013) 1.31
Risk factors for decreased bone density and effects of HIV on bone in the elderly. Osteoporos Int (2007) 1.27
Physiologic frailty and fragility fracture in HIV-infected male veterans. Clin Infect Dis (2013) 1.26
The Role of Inflammatory Cytokines, the RANKL/OPG Axis, and the Immunoskeletal Interface in Physiological Bone Turnover and Osteoporosis. Scientifica (Cairo) (2013) 1.20
Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study. AIDS (2010) 1.19
Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women. J Clin Endocrinol Metab (2009) 1.16
Higher rates of bone loss in postmenopausal HIV-infected women: a longitudinal study. J Clin Endocrinol Metab (2011) 1.16
Human immunodeficiency virus and highly active antiretroviral therapy-associated metabolic disorders and risk factors for cardiovascular disease. Metab Syndr Relat Disord (2009) 1.13
WNT/beta-catenin signaling is involved in regulation of osteoclast differentiation by human immunodeficiency virus protease inhibitor ritonavir: relationship to human immunodeficiency virus-linked bone mineral loss. Am J Pathol (2008) 1.09
Functional impairment is associated with low bone and muscle mass among persons aging with HIV infection. J Acquir Immune Defic Syndr (2013) 1.07
Prospective study of bone mineral density changes in aging men with or at risk for HIV infection. AIDS (2010) 1.06
HIV-1 infection and antiretroviral therapies: risk factors for osteoporosis and bone fracture. Curr Opin Endocrinol Diabetes Obes (2010) 1.05
Vitamin D deficiency in HIV-infected postmenopausal Hispanic and African-American women. Osteoporos Int (2010) 1.03
Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART body composition substudy. J Bone Miner Res (2013) 1.03
Mucosal immunity in human and simian immunodeficiency lentivirus infections. Mucosal Immunol (2013) 0.96
HIV and bone metabolism. Discov Med (2011) 0.95
Increased Fracture Incidence in Middle-Aged HIV-Infected and HIV-Uninfected Women: Updated Results From the Women's Interagency HIV Study. J Acquir Immune Defic Syndr (2015) 0.94
Prevalence of and risk factors for low bone mineral density in untreated HIV infection: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial. HIV Med (2015) 0.91
Lower peak bone mass and abnormal trabecular and cortical microarchitecture in young men infected with HIV early in life. AIDS (2014) 0.90
Characteristics of foot fractures in HIV-infected patients previously treated with tenofovir versus non-tenofovir-containing highly active antiretroviral therapy. HIV AIDS (Auckl) (2011) 0.85
Prospective evaluation of bone mineral density among middle-aged HIV-infected and uninfected women: Association between methadone use and bone loss. Maturitas (2011) 0.85
HIV prevalence and sexual behaviour at older ages in rural Malawi. Int J STD AIDS (2012) 0.82
Impact of age on markers of HIV-1 disease. Future Virol (2013) 0.82
Bone disease in HIV infection. Clin Cases Miner Bone Metab (2011) 0.81
Does HIV infection have an impact upon dental implant osseointegration? A systematic review. Med Oral Patol Oral Cir Bucal (2015) 0.81
Trabecular and cortical microarchitecture in postmenopausal HIV-infected women. Calcif Tissue Int (2013) 0.80
High prevalence of low bone mass and associated factors in Korean HIV-positive male patients undergoing antiretroviral therapy. J Int AIDS Soc (2014) 0.80
Abnormal thyroid function in older men with or at risk for HIV infection. HIV Med (2008) 0.79
Care of the human immunodeficiency virus-infected menopausal woman. Am J Obstet Gynecol (2011) 0.79
Reduced quantitative ultrasound bone mineral density in HIV-infected patients on antiretroviral therapy in Senegal. PLoS One (2012) 0.79
Prevalence and risk factors for osteopenia/osteoporosis in an HIV-infected male population. Wien Klin Wochenschr (2007) 0.78
The unsolved case of "bone-impairing analgesics": the endocrine effects of opioids on bone metabolism. Ther Clin Risk Manag (2015) 0.78
Role of bone mineral density in predicting morphometric vertebral fractures in patients with HIV infection. Osteoporos Int (2014) 0.78
HIV infection and osteoporosis. Bonekey Rep (2015) 0.77
Prevalence of and risk factors for osteoporosis and fracture among a male HIV-infected population in the UK. Int J STD AIDS (2013) 0.77
Comparative risk of fracture in men and women with HIV. J Clin Endocrinol Metab (2013) 0.77
Fall frequency and associated factors among men and women with or at risk for HIV infection. HIV Med (2016) 0.76
DUAL-ENERGY X-RAY ABSORPTIOMETRY AND CALCULATED FRAX RISK SCORES MAY UNDERESTIMATE OSTEOPOROTIC FRACTURE RISK IN VITAMIN D-DEFICIENT VETERANS WITH HIV INFECTION. Endocr Pract (2015) 0.76
Fracture management in HIV positive individuals: a systematic review. Int Orthop (2016) 0.76
Lifetime and recent alcohol use and bone mineral density in adults with HIV infection and substance dependence. Medicine (Baltimore) (2017) 0.75
Prevalence and risk factors of low bone mineral density in Korean HIV-infected patients: impact of abacavir and zidovudine. J Korean Med Sci (2013) 0.75
Serum Sclerostin Levels in Patients with Human Immunodeficiency Virus Infection and Their Association with Bone Turnover Markers and Bone Mineral Densitometry. J Bone Metab (2016) 0.75
Nonsurgical Management of Severe Osteonecrosis of the Knee in an HIV-Positive Patient: A Case Report. Case Rep Infect Dis (2011) 0.75
Does systemic inflammation and immune activation contribute to fracture risk in HIV? Curr Opin HIV AIDS (2016) 0.75
Validation Protocol of Vitamin D Supplementation in Patients with HIV-Infection. AIDS Res Treat (2016) 0.75
Perspectives on menopause and women with HIV. Int J Womens Health (2016) 0.75
An Increased Rate of Fracture Occurs a Decade Earlier in HIV+ Compared to HIV- men in the Multicenter AIDS Cohort Study (MACS). AIDS (2017) 0.75
Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial. JAMA (2004) 10.40
Epidemiology of osteoporosis and osteoporotic fractures. Epidemiol Rev (1985) 7.40
Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med (1995) 5.27
Cigarette smoking, relative weight, and menopause. Am J Epidemiol (1983) 4.46
Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy. AIDS (2000) 3.39
Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis (2005) 2.55
Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals. Clin Infect Dis (2003) 2.20
A meta-analysis of cigarette smoking, bone mineral density and risk of hip fracture: recognition of a major effect. BMJ (1997) 2.18
Race and sex effects on the association between muscle strength, soft tissue, and bone mineral density in healthy elders: the Health, Aging, and Body Composition Study. J Bone Miner Res (2001) 2.16
Prevalence of low femoral bone density in older U.S. women from NHANES III. J Bone Miner Res (1995) 2.12
Low lumbar bone mineral density in patients with major depression. Am J Psychiatry (1994) 2.05
Bone mineral density in women with depression. N Engl J Med (1996) 2.03
Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy. AIDS (2003) 1.89
A longitudinal analysis of the association between menopause and depression. Results from the Massachusetts Women's Health Study. Ann Epidemiol (1994) 1.81
Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis (2003) 1.70
Reduced bone density in HIV-infected women. AIDS (2004) 1.70
Sex steroids and bone mass. A study of changes about the time of menopause. J Clin Invest (1987) 1.68
Osteopenia in HIV-infected women prior to highly active antiretroviral therapy. J Infect (2003) 1.52
Stable or increasing bone mineral density in HIV-infected patients treated with nelfinavir or indinavir. AIDS (2001) 1.50
BMD is reduced in HIV-infected men irrespective of treatment. J Bone Miner Res (2003) 1.45
Body composition and endocrine function in women with acquired immunodeficiency syndrome wasting. J Clin Endocrinol Metab (1997) 1.36
Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia. J Clin Endocrinol Metab (2004) 1.32
Reduced bone mineral density in HIV-positive individuals. AIDS (2001) 1.26
Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy. AIDS (2001) 1.22
Osteopenia in HIV-infected patients: is it the disease or is it the treatment? AIDS (2001) 1.21
Prevalence and predictive value of overweight in an urban HIV care clinic. J Acquir Immune Defic Syndr (2001) 1.10
Increased urinary catechol estrogen excretion in female smokers. Steroids (1989) 1.02
Opiate drug use: a potential contributor to the endocrine and metabolic complications in human immunodeficiency virus disease. Clin Infect Dis (2003) 0.95
Determinants of peak bone mass and mechanisms of bone loss. Osteoporos Int (1999) 0.94
Osteopenia and osteoporosis in HIV+ patients, untreated or receiving HAART. Biomed Pharmacother (2004) 0.91
Body composition and nutritional parameters in HIV and AIDS patients. Clin Chem Lab Med (2002) 0.89
Osteopenia in patients infected by the human immunodeficiency virus. A case control study. Joint Bone Spine (2002) 0.84
Testosterone replacement treatment options for HIV-infected men. J Acquir Immune Defic Syndr Hum Retrovirol (1997) 0.82
Bone mass in HIV-infected patients: focus on the role of therapy and sex. J Acquir Immune Defic Syndr (2003) 0.81
Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. J Gen Intern Med (2002) 5.30
Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study. JAMA (2004) 3.85
A prospective study of adherence and viral load in a large multi-center cohort of HIV-infected women. AIDS (2002) 3.41
Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst (2003) 2.81
HIV infection and bone mineral density in middle-aged women. Clin Infect Dis (2006) 2.67
Androgen levels in older men who have or who are at risk of acquiring HIV infection. Clin Infect Dis (2005) 2.55
The clonality of Staphylococcus aureus nasal carriage. J Infect Dis (2005) 2.39
Gender differences in factors associated with adherence to antiretroviral therapy. J Gen Intern Med (2004) 2.37
Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women. AIDS (2008) 2.28
Burden of asthma in inner-city elementary schoolchildren: do school-based health centers make a difference? Arch Pediatr Adolesc Med (2003) 2.18
Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy. Clin Infect Dis (2005) 2.15
Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr (2003) 2.11
Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis (2001) 1.79
Familial and cultural perceptions and beliefs of oral hygiene and dietary practices among ethnically and socio-economicall diverse groups. Community Dent Health (2004) 1.78
Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clin Infect Dis (2002) 1.73
Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study. Clin Infect Dis (2006) 1.72
Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.71
Obesity and dental caries in children: a systematic review and meta-analysis. Community Dent Oral Epidemiol (2012) 1.71
Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis (2003) 1.70
Strains of Staphylococcus aureus obtained from drug-use networks are closely linked. Clin Infect Dis (2002) 1.63
Oral health-related quality of life for 8-10-year-old children: an assessment of a new measure. Community Dent Oral Epidemiol (2005) 1.60
Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. J Infect Dis (2003) 1.57
The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol (2009) 1.56
Empirical evidence of the relationship between parental and child dental fear: a structured review and meta-analysis. Int J Paediatr Dent (2010) 1.49
Association of pelvic organ prolapse and fractures in postmenopausal women: analysis of baseline data from the Women's Health Initiative Estrogen Plus Progestin trial. Menopause (2008) 1.47
Interpreting the association between HIV and bone mineral density. AIDS (2007) 1.43
HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clin Infect Dis (2011) 1.37
Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV. J Low Genit Tract Dis (2007) 1.37
Peripheral blood cytokine profiling during pregnancy and post-partum periods. Am J Reprod Immunol (2010) 1.37
Reliability and validity of a faces version of the Modified Child Dental Anxiety Scale. Int J Paediatr Dent (2007) 1.37
Validation data-based adjustments for outcome misclassification in logistic regression: an illustration. Epidemiology (2011) 1.35
Reforming NHS dentistry. BMJ (2008) 1.35
Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection. Clin Infect Dis (2002) 1.35
International comparisons of health inequalities in childhood dental caries. Community Dent Health (2004) 1.34
Psychological stress in undergraduate dental students: baseline results from seven European dental schools. Eur J Dent Educ (2002) 1.34
Current sexual activity and risky sexual behavior in older men with or at risk for HIV infection. AIDS Educ Prev (2007) 1.33
Recognizing and reporting child physical abuse: a survey of primary healthcare professionals. J Adv Nurs (2006) 1.33
High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. Obstet Gynecol (2010) 1.31
Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. Int J Cancer (2006) 1.28
Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.28
Menopause symptoms in HIV-infected and drug-using women. Menopause (2005) 1.27
Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. J Infect Dis (2003) 1.27
HIV infection, drug use, and onset of natural menopause. Clin Infect Dis (2005) 1.24
Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 1.24
Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men. AIDS Patient Care STDS (2007) 1.22
Disorders of glucose metabolism among HIV-infected women. Clin Infect Dis (2005) 1.22
TB diagnostic capacity in sub-Saharan African HIV care settings. J Acquir Immune Defic Syndr (2012) 1.22
Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection. J Acquir Immune Defic Syndr (2004) 1.21
MicroRNAs regulate tumor angiogenesis modulated by endothelial progenitor cells. Cancer Res (2012) 1.21
Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women. J Acquir Immune Defic Syndr (2003) 1.20
Fat distribution in HIV-infected women in the United States: DEXA substudy in the Women's Interagency HIV Study. J Acquir Immune Defic Syndr (2005) 1.20
Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women. Am J Epidemiol (2006) 1.20
The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. J Acquir Immune Defic Syndr (2003) 1.19
Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women. Cancer Epidemiol Biomarkers Prev (2005) 1.17
Characterizing the pregnancy immune phenotype: results of the viral immunity and pregnancy (VIP) study. J Clin Immunol (2011) 1.16
Longitudinal trends in hazardous alcohol consumption among women with human immunodeficiency virus infection, 1995-2006. Am J Epidemiol (2009) 1.16
Incidence and clinical features of cerebrovascular disease among HIV-infected adults in the Southeastern United States. AIDS Res Hum Retroviruses (2013) 1.15
Crack cocaine use and other risk factors for tuberculin positivity in drug users. Clin Infect Dis (2002) 1.14
Impact of drug abuse treatment modalities on adherence to ART/HAART among a cohort of HIV seropositive women. Am J Drug Alcohol Abuse (2008) 1.14
The association of bone mineral density with HIV infection and antiretroviral treatment in women. Antivir Ther (2007) 1.13
Sleep Complaints of Postmenopausal Women. Clin J Womens Health (2001) 1.13
Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. Am J Obstet Gynecol (2002) 1.12
Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users. Clin Infect Dis (2003) 1.12
Developing explanatory models of health inequalities in childhood dental caries. Community Dent Health (2004) 1.10
Suppression of tumor growth in vivo by the mitocan alpha-tocopheryl succinate requires respiratory complex II. Clin Cancer Res (2009) 1.09
Variations in hip fracture hospitalization rates among different race/ethnicity groups in New York City. Ethn Dis (2004) 1.08
Mitocans as anti-cancer agents targeting mitochondria: lessons from studies with vitamin E analogues, inhibitors of complex II. J Bioenerg Biomembr (2007) 1.08
Vitamin E analogues as a novel group of mitocans: anti-cancer agents that act by targeting mitochondria. Mol Aspects Med (2007) 1.07
Total laparoscopic hysterectomy versus da Vinci robotic hysterectomy: is using the robot beneficial? J Gynecol Oncol (2011) 1.07
Prospective study of bone mineral density changes in aging men with or at risk for HIV infection. AIDS (2010) 1.06
Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation. J Infect Dis (2004) 1.04
Self-perception of body fat changes and HAART adherence in the Women's Interagency HIV Study. AIDS Behav (2008) 1.04
Alcohol consumption trajectory patterns in adult women with HIV infection. AIDS Behav (2013) 1.03
Gender differences in illicit substance use among middle-aged drug users with or at risk for HIV infection. Clin Infect Dis (2006) 1.02
The Nursing Education Partnership Initiative (NEPI): innovations in nursing and midwifery education. Acad Med (2014) 1.01
UK population norms for the modified dental anxiety scale with percentile calculator: adult dental health survey 2009 results. BMC Oral Health (2013) 1.00
A systematic review and meta-analysis of face-to-face communication of tailored health messages: implications for practice. Patient Educ Couns (2011) 0.99
Remembering and repeating childhood dental treatment experiences: parents, their children, and barriers to dental care. Int J Paediatr Dent (2009) 0.99
Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging. AIDS (2009) 0.99
Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999. J Urban Health (2003) 0.99